Abstract
Many advances in our knowledge about liver disease have followed the wider use of liver biopsy, and development of techniques such as ultrasonography, magnetic resonance and computed tomography. Nevertheless, blood tests remain the first investigations in the assessment of liver dysfunction. None of the tests is entirely specific, and interpretation usually depends on examination of a constellation of results together with the clinical presentation. There is no true ‘liver function test’, but merely abnormal serum biochemistry which could be explained by liver disease.
The original version of this chapter was revised. An erratum to this chapter can be found at 10.1007/978-3-319-53786-3_17
Bibliography
Adachi Y, Horii K, Takahashi Y, Tanahata H, Ohba Y, Yamamoto T. Serum glutathione S-transferase activity in liver diseases. Clin Chim Acta. 1980;106:243–55.
Aragona M, Caredda F, Lavarini C, et al. Serological response to the hepatitis delta virus in hepatitis D. Lancet. 1987;1:478–80.
Arico S, Aragona M, Rizzetto M, et al. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet. 1985;2:356–8.
Bell H, Tallaksen C, Sjaheim T, Weberg R, Raknerud N, Orjasaeter H, Try K, Haug E. Serum carbohydrate deficient transferrin as a marker of alcohol consumption in patients with chronic liver diseases. Alcohol Clin Exp Res. 1993;17:246–52.
Ben Porath E, Wands JR. Monoclonal antibodies as diagnostic probes in the etiology of hepatitis. Semin Liver Dis. 1984;4:76–88.
Berg PA, Klein R, Lindenborn-Fotinos J, et al. ATP-ase-associated antigen (M2); marker antigen for serological diagnosis ofPBC. Lancet. 1982;2:1423–6.
Blum HE, Haase AT, Vyas GN. Molecular pathogenesis of hepatitis B virus infection: simultaneous detection of viral DNA and antigens in paraffin-embedded liver sections. Lancet. 1984;2:881–4.
Brugmann E, Towe J. Indocyanine green clearance in a liver function test. Mater Med Pol. 1974;6:123–6.
Burrows S, Feldman W, McBride F. Serum gamma-glutamyl transpeptidase. Am J Clin Pathol. 1975;65:311–4.
Chalmers OM, Rinsler MG, MacDermott S, Spicer CC, Levi AJ. Biochemical and haematological indicators of excessive alcohol consumption. Gut. 1981;22:992–6.
Chen D-S, Sung J-L, et al. Serum alpha-fetoprotein in the early stage of human hepatocellular carcinoma. Gastroenterology. 1984;86:1404–9.
Coken JA, Kaplan MM. The SGOT/SGPT ratio - an indicator of alcoholic liver disease. Dig Dis Sci. 1979;24:835–8.
Colombo M, Cambieri R, Rumi MG, Ronchi G, Del Ninno E, De Franchis R. Long-term delta superinfection in HBsAg carriers and its relationship to the course of chronic hepatitis. Gastroenterology. 1983;85:235–9.
Doniach D, Walker GJ. Mitochondrial antibodies (AMA). Gut. 1974;IS:664–8.
Engelking LR, Dasher CA, Bl H. Within-day fluctuation in serum bile acid concentration among normal control subjects and patients with hepatic disease. Am J Clin Pathol. 1980;73:196–201.
Fagan EA, Williams R. Serological responses to HBV infection. Gut. 1986;27:858–67.
Felding RH, Christensen RF, Lindahl F. Ammonia tolerance test. Scand J Gastroenterol. 1984;19:365–8.
Felsher BF, Carpoi NM. Calorie intake in unconjugated hyperbilirubinaemia. Gastroenterology. 1975;69:42–7.
Ferraris R, Fiorentini MT, Galatola G, Rolfo P, De la Pierre M. Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases: comparison with levels of 3-alpha-hydroxy bile acids determined enzymatically and with routine liver tests. Dig Dis Sci. 1987;32:817–23.
Finch CA, Huebers H. Perspectives in iron metabolism. N Engl J Med. 1982;306:1520–9.
Gollan JL. Diagnosis of haemochromatosis. Gastroenterology. 1983;84:418–31.
Grace ND, Castell DO, Wennar MH. A comparison of the oral fructose and ammonia tolerance tests in cirrhosis. Arch Intern Med. 1969;124:330–6.
Halliday JW, Russo A, Collishaw J, Powell LW. Serum ferritin in the diagnosis of early haemochromatosis: a study of 43 families. Lancet. 1977;2:621–3.
Holstege A, Staiger M, Haag K, Gerok W. Correlation of caffeine elimination and Child's classification in liver cirrhosis. Klin Wochenschr. 1989;67:6–15.
Hoofnagle JH, Type D. Hepatitis and the hepatitis delta antigen. In: Thomas HC, Jones EA, editors. Recent advances in hepatology. Edinburgh: Churchill Livingstone; 1986. p. 73–92.
Javitt NB. Clinical and experimental aspects of sulphobromophthalein and related compounds. Prog Liver Dis. 1970;3:110–7.
Killenberg PF, Stevens RD, Wilderman RF, Wilderman NM. The laboratory method as a variable in the interpretation of serum bilirubin fractionisation. Gastroenterology. 1980;78:1011–5.
Kuroki S, Okamoto S, Naito T, et al. Serum 7-a1pha OH cholesterol as a new parameter of liver function in patients with chronic liver diseases. Hepatology. 1995;22:1182–7.
Lavarini C, Farci P, Chiaberge E, et al. IgM antibody against hepatitis B core antigen (lgM HBcAb): diagnostic and prognostic significance in acute HBsAg positive hepatitis. BMJ. 1983;287:1254–6.
Le P, Langlois S. Fine needle biopsy of hepatic hydatids and haemangiomas: an overstated hazard. Australas Radiol. 1989;2:144–9.
Lewis KO, Nicholson G, Lance P, Paton A. Aminopyrine breath test in alcoholic liver disease and in patients on enzyme inducing drugs. J Clin PathoI. 1977;30:1040–3.
Lindsay KL, Nizze JA, Koretz R, Gitnick E. Diagnostic usefulness of testing for HBcAb IgM in acute hepatitis B. Hepatology. 1986;6:1325–8.
Luey KL, Heaton KW. Bile acid clearance in liver disease. Gut. 1979;20:1083–7.
Mannes GA, Thieme C, Stellard F, Wang T, Sauerbruck T, Paumgartner G. The prognostic significance of serum bile acids in cirrhosis. Hepatology. 1986;6:50–3.
Manns MP, Nakamura RM. Auto immune liver diseases. Clin Lab Med. 1988;8:281–301.
McDonagh JE, Nathan VV, Bonavia IC, Moyle GR, Tanner AR. Caffeine clearance by enzyme multiplied immunoassay technique: a simple inexpensive and useful indicator of liver function. Gut. 1991;32:681–4.
Moore, MR. Porphyria. Glasgow, Porphyria Research Unit, Western Infirmary, 1994.
Mulder AHL, Horst G, Haagsma EB, Limburg PC, Kleibeuker JH, Kallewberg CGM. Prevalence and characterisation of neutrophil cytoplastic antibodies in AILD. Hepatology. 1993;17:411–7.
Murew J, Kierulf P. The intravenous galactose test as indication of the extent of fibrosis in patients with cirrhosis of the liver. Scand J Gastroenterol. 1969;4:453–6.
Nalpas B, Vassault A, Charpin S, Lacour B, Berthelot P. Serum mitochondrial (m) AST as a marker of chronic alcoholism: diagnostic volume and interpretation in a liver unit. Hepatology. 1986;4:608–14.
Olynyk J, Hall P, Sallie R, Reed W, Shilkin K, Mackinnon M. Computerised measurement of iron in liver biopsies: a comparison with biochemical iron measurement. Hepatology. 1990;12:26–30.
Owens D, Sherlock S. The diagnosis of Gilbert’s syndrome: role of the reduced calorie intake test. BMJ. 1973;3:559–63.
Penn R, Worthington OJ. Is serum gamma-glutamyltransferase a misleading test? BMJ. 1983;286:531–5.
Poynard J, Aubert A, Bedossa P, et al. A simple biological index for detection of ALD in drinkers. Gastroenterology. 1991;100:1397–402.
Reichling JJ, Kaplan MM. Clinical use of serum enzymes in liver disease. Dig Dis Sci. 1988;33:1601–14.
Saunders JB, Lewis KO, Paton A. Early diagnosis of alcoholic cirrhosis by the aminopyrine breath test. Gastroenterology. 1980;79:112–4.
Scharshmidt BF, Blankaert N, Farina FA, Kabra PM, Stafford BE, Weisiger RA. Measurement of serum bilirubin and its mono- and disconjugates: applicability to patients with hepatobiliary disease. Gut. 1982;23:643–9.
Skillen AW, Fifield RD, Sheraidah GS. Serum alkaline phosphatase isoenzyme patterns in disease. Clin Chim Acta. 1972;40:21–5.
Skinner HA, Holt S, Sheu WJ, Israel Y. Clinical versus laboratory detection of alcohol abuse: the alcohol clinical index. BMJ. 1986;292:1703–8.
Solberg HE, Skrede S, Blomhoff JP. Diagnosis of liver diseases by laboratory results and discriminant analysis. Scand J Clin Lab Invest. 1975;35:713–21.
Tabor E. The three viruses of non-A, non-B hepatitis. Lancet. 1985;1:743–5.
Triger DR. Auto-immune chronic active hepatitis and primary biliary cirrhosis. Clin Gastroenterol. 1989;3:21–38.
Van Der Poel CL, Cuypers HTM, Reesink HW, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet. 1991;337:317–9.
Van Wates L, Lieber C. Glutamate dehydrogenase: a reliable marker of liver cell necrosis in the alcoholic. BMJ. 1977;2:1508–10.
Wantzin P, Nielsen JO, Tygstrup N, Soerensen H, Dybkjaer E. Screening of Danish blood donors for hepatitis B surface antigen using a third generation technique. BMJ. 1985;291:780–2.
Williams ALB, Hoofnagle JH. Ratio of serum aspartate to alanine aminotansferase in chronic hepatitis. Gastroenterology. 1988;95:734–9.
Yamanishi Y, Kishimotor Y, Kawasaki H, Hirayama C, Ikawa S. Oral ursodeoxycholic acid tolerance test in patients with digestive diseases. Gastroenterol Jpn. 1981;16:472–7.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Bateson, M.C., Bouchier, I.A.D. (2017). Liver Biochemistry. In: Clinical Investigations in Gastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-319-53786-3_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-53786-3_12
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-53785-6
Online ISBN: 978-3-319-53786-3
eBook Packages: MedicineMedicine (R0)